Search
for
Sort by
Research 511–540 of 1000+
- Comparison of clinical trials with finasteride and dutasteride.
- Fixed-dose combination PRO 160/120 of sabal and urtica extracts improves nocturia in men with LUTS suggestive of BPH: re-evaluation of four controlled clinical studies
- Risk of Depression Associated With Finasteride Treatment
- Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
- Steroid 5α-reductase inhibition by polymethoxyflavones
- Discovery of novel 5α-reductase type II inhibitors by pharmacophore modelling, virtual screening, molecular docking and molecular dynamics simulations
- Permanent chemotherapy-induced alopecia after hematopoietic stem cell transplantation treated with low-dose oral minoxidil
- Urinary Incontinence due to Overactive Detrusor Muscle: A Rare Side Effect of Venlafaxine
- WS PRO 160 I 120 mg (a combination of sabal and urtica extract) in patients with LUTS related to BPH
- Scientific Evaluation of A Unani Pharmacopoeia-Based Formulation on BPH in Animal Model
- Lipid Profile and 5α-Reductase Inhibition Activity of Proprietary Ultrahigh-Pressure Supercritical Carbon Dioxide and Hexane Saw Palmetto Extracts
- 5‐Alpha reductase inhibitor related litigation: A legal database review
- 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond
- Finasterid in der Behandlung der benignen Prostatahyperplasie
- Comparative Effect of Finasteride and Dutasteride on Chromogranin A Levels
- The urologic impact of long-term finasteride 1-mg use for androgenic alopecia: a matched-cohort database analysis
- Can we identify a post‐Serenoa syndrome (PSS)? A case series on sexual and psychiatric side effects of <i>Serenoa repens</i>
- Differential association between cumulative dose of 5α-reductase inhibitors and mortality
- Drug Discovery Insights from a Computational QSAR Study on Alpha-Reductase Inhibitors and Layered Double Hydroxides Electrocatalysts
- Дослідження ПРОСПЕКТ IV (ПРОСтамол: ПЕрспективи Комбінованої Терапії) у хворих на доброякісну гіперплазію передміхурової залози
- New Drugs: Dutasteride
- Why would men use finasteride in 2005?
- US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know?
- En pacientes jóvenes, el uso de finasteride podría asociarse con mayor riesgo de ansiedad, depresión y eventos adversos relacionados con el suicidio
- Hiperplasia quística prostática en un perro joven: reporte de caso
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm
- A comment on the post-finasteride syndrome
- Finasteride Use and Risk of Male Breast Cancer: A Case–Control Study Using Individual-Level Registry Data from Denmark, Finland, and Sweden